『The Clinical Realist』のカバーアート

The Clinical Realist

The Clinical Realist

著者： Dr. Sarah Matt
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり

Healthcare innovation is broken. We have billion-dollar AI running on 1990s infrastructure. We have startups dying in "Pilotitis." And we have leaders frozen by analysis paralysis.

Dr. Sarah Matt (The Clinical Realist) is here to fix the disconnect between the tech stack and the trauma bay.

Join Dr. Matt—physician, strategist, and author of The Borderless Healthcare Revolution—as she cuts through the hype to reveal what actually works in modern medicine. No buzzwords. No fluff. Just the raw, unvarnished truth about how to lead, build, and survive in the future of healthcare.

If you are tired of the "Star Trek" vision and want the "Clinical Reality," this is your show.

Subscribe to The Sarah Matt Briefing for weekly insights on healthcare AI, access strategy, and the business of medicine: https://drsarahmatt.com/newsletter-signup

© 2026 The Clinical Realist マネジメント マネジメント・リーダーシップ 経済学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • What a Medical Bill Actually Is, with Amy Stillman

    What a Medical Bill Actually Is, with Amy Stillman
    2026/10/07
    The encounter ends, the patient goes home, and then a bill arrives. Amy Stillman argues that a medical bill is not a payment reminder. Patients frequently do not understand what happened to them, what they owe, or what they are supposed to do next, and the bill lands after the frightening part is already over. Stillman is Chief Product Officer at Cedar, where she has run product, design, research, and data science since 2019. She is an industrial designer by training, not an engineer and not a revenue cycle specialist, which turns out to matter. She and Dr. Sarah Matt cover where Cedar sits among payers, EHRs, and clearinghouses, and why a patient should not be reduced to a single true or false signal from one system. Much of the conversation is about Cora, Cedar's AI agent, which Stillman says resolves about 40 percent of its calls, and which is designed against three measures at once: cost to serve, resolution rate, and patient satisfaction. She makes the case for tracking resolution rather than collection, since the right outcome may be a corrected insurance record, a Medicaid redetermination, financial aid, or a discount paired with a payment plan. She also names the group Cedar finds hardest to help: patients just above the financial aid cutoff, called ALICE by United Way, asset limited, income constrained, but employed. Find Amy: cedar.com | linkedin.com/in/amystillman

    —

    Resources & Links:

    📖 Get the Book: "The Borderless Healthcare Revolution" is available now on Amazon and major retailers.

    💼 Work with Dr. Matt:
    Looking for a keynote speaker or strategic advisor?
    Visit: drsarahmatt.com

    🔗 Connect on Social:
    LinkedIn: https://www.linkedin.com/in/sarahmattmd/
    YouTube: https://www.youtube.com/@DrSarahMatt-ClinicalRealist

    📧 Subscribe to The Briefing: drsarahmatt.com/newsletter-signup

    —
    Disclaimer:
    The views expressed on this podcast are those of Dr. Sarah Matt and her guests. They do not necessarily reflect the official policy or position of any affiliated institutions. This content is for informational and educational purposes only and does not constitute medical advice or a professional consulting relationship.
    続きを読む 一部表示
    26 分
  • What Longitudinal Data Actually Contains, with Shashi Shankar

    What Longitudinal Data Actually Contains, with Shashi Shankar
    2026/09/30
    Start with a number. In a registry of about 6,000 patients on GLP-1 medications, roughly 45 percent have taken two or more versions of the drug, most often moving from semaglutide to tirzepatide. The largest published study, about 127,000 adults, puts 12-month switching closer to 20 percent. Nobody can fully verify either figure, because no single system holds the whole record. Shashi Shankar spent nearly a decade at Genentech working on real world data before co-founding Novellia, where he is chief executive. The product pulls a patient's records out of every patient portal they have ever logged into, across roughly 25 years of care. Biopharmaceutical researchers pay for de-identified access. Patients never pay at all. He and Dr. Sarah Matt walk through where records actually fragment: community clinic to lab to academic specialist, and inside a single health system when the hub and the community site sit two hours apart. Shankar describes the load carried by family caregivers, and explains why he considers tokenized data brokerage a poor substitute, with each join between data sets hitting at 15 to 20 percent and leaving a snapshot frozen in time. Matt presses on the part still unsolved: the record reaches the patient, and it still does not reach the prescriber. Find Shashi: novellia.com | search his name with Novellia on LinkedIn

    —

    Resources & Links:

    📖 Get the Book: "The Borderless Healthcare Revolution" is available now on Amazon and major retailers.

    💼 Work with Dr. Matt:
    Looking for a keynote speaker or strategic advisor?
    Visit: drsarahmatt.com

    🔗 Connect on Social:
    LinkedIn: https://www.linkedin.com/in/sarahmattmd/
    YouTube: https://www.youtube.com/@DrSarahMatt-ClinicalRealist

    📧 Subscribe to The Briefing: drsarahmatt.com/newsletter-signup

    —
    Disclaimer:
    The views expressed on this podcast are those of Dr. Sarah Matt and her guests. They do not necessarily reflect the official policy or position of any affiliated institutions. This content is for informational and educational purposes only and does not constitute medical advice or a professional consulting relationship.
    続きを読む 一部表示
    33 分
  • Who Gets to Say No in Health IT, with Anthony Guerra

    Who Gets to Say No in Health IT, with Anthony Guerra
    2026/09/23
    Anthony Guerra has asked roughly the same question about 600 times. He founded Health System CIO in 2010 and has covered health information technology since 2005, which is 16 years sitting across from the people who sign off on what technology actually enters a hospital: CIOs, CMIOs, and Chief Information Security Officers, across three or four full technology cycles. Most people in health tech can tell you what a CIO says about AI right now. Almost nobody can tell you how the answer moved. Dr. Sarah Matt asks Guerra exactly that: not the vocabulary, which turns over every 18 months, but the posture. Where the hedging went, what they stopped apologizing for, and what they are still unwilling to say into a microphone. What comes out: why governance is the fix that solves the downstream problems, and why nobody yet owns responsibility for agentic activity. Why shadow IT is an indicator rather than a failure. Why a successful pilot is proof the pilot worked and nothing more. Why nobody gets fired for staying in suite. The number one CIO skill, which has very little to do with technology. And healthcare's structural inability to say no, shut it off, or cancel the contract, which Guerra argues is about to become a very large problem when the thing you need to shut off is an agent. Find Anthony: healthsystemcio.com | linkedin.com/in/anthonyguerra

    —

    Resources & Links:

    📖 Get the Book: "The Borderless Healthcare Revolution" is available now on Amazon and major retailers.

    💼 Work with Dr. Matt:
    Looking for a keynote speaker or strategic advisor?
    Visit: drsarahmatt.com

    🔗 Connect on Social:
    LinkedIn: https://www.linkedin.com/in/sarahmattmd/
    YouTube: https://www.youtube.com/@DrSarahMatt-ClinicalRealist

    📧 Subscribe to The Briefing: drsarahmatt.com/newsletter-signup

    —
    Disclaimer:
    The views expressed on this podcast are those of Dr. Sarah Matt and her guests. They do not necessarily reflect the official policy or position of any affiliated institutions. This content is for informational and educational purposes only and does not constitute medical advice or a professional consulting relationship.
    続きを読む 一部表示
    34 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません